SHMT2 has been implicated in Alzheimer's disease (AD) pathology through its role in enhancing ADAM10 translation via interaction with the 5' untranslated region of ADAM10 mRNA. This evidence concerns the gene ADAM10 and early-onset autosomal dominant Alzheimer disease.